Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RENAL CELL CARCINOMA

Proteomic signatures of clear cell renal cell carcinoma

Nature Reviews Nephrology volume 16, pages 133–134 (2020)Cite this article

Subjects

In recent years, the molecular view of clear cell renal cell carcinoma (ccRCC) has been based primarily on gene transcription data with limited information on protein features. A new study led by the Clinical Proteomic Tumor Analysis Consortium now offers a comprehensive view of the ccRCC proteome.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CPTAC versus TCGA ccRCC proteomic data.

References

  1. Clark, D. et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964–983 (2019).

    Article  CAS  Google Scholar 

  2. Akbani, R. et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat. Commun. 5, 3887 (2014).

    Article  CAS  Google Scholar 

  3. Zhang, Y. et al. A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations. Cancer Cell 31, 820–832 (2017).

    Article  CAS  Google Scholar 

  4. Chen, F. et al. Multilevel genomics-based taxonomy of renal cell carcinoma. Cell Rep. 14, 2476–2489 (2016).

    Article  CAS  Google Scholar 

  5. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal cell carcinoma. N. Engl. J. Med. 374, 135–145 (2015).

    Article  Google Scholar 

  6. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).

    Article  Google Scholar 

  7. Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas pan-cancer analysis project. Nat. Genet. 45, 1113–1120 (2013).

    Article  Google Scholar 

  8. Edwards, N. et al. The CPTAC data portal: a resource for cancer proteomics research. J. Proteome. Res. 14, 2707–2713 (2015).

    Article  CAS  Google Scholar 

  9. Chandrashekar, D. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649–658 (2017).

    Article  CAS  Google Scholar 

  10. Davis, C. et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26, 319–330 (2014).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by National Institutes of Health (NIH) grant P30CA125123.

Author information

Authors and Affiliations

  1. Department of Medicine and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA

    Chad J. Creighton

Authors
  1. Chad J. Creighton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chad J. Creighton.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Creighton, C.J. Proteomic signatures of clear cell renal cell carcinoma. Nat Rev Nephrol 16, 133–134 (2020). https://doi.org/10.1038/s41581-019-0233-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-019-0233-5

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer